You are here

News

Coverage of the latest news and updates from the field of stem cells and regenerative medicine.

August 20, 2014

Hematopoietic stem cells (HSCs) give rise to all other blood cell types, but their development and how their fate is determined has long remained a mystery.

August 20, 2014

The phase I arm of the RETRO-HF clinical trial to treat patients with advanced heart failure using stem cells delivered via “retrograde infusion” has been successfully completed, according to Juventas Therapeutics (Cleveland), the company that provided the cells and delivery method to the trial s

August 20, 2014

The phase I arm of the RETRO-HF clinical trial to treat patients with advanced heart failure using stem cells delivered via “retrograde infusion” has been successfully completed, according to Juventas Therapeutics (Cleveland), the company that provided the cells and delivery method to the trial s

August 19, 2014

Researchers at the University of California, San Diego School of Medicine have launched a clinical trial to investigate the safety of neural stem cell transplantation in patients with chronic spinal cord injuries. This phase 1 clinical trial is recruiting 8 patients for the 5-year study.

August 18, 2014

Cytori Therapeutics has placed enrollment in its ATHENA and ATHENA I clinical trials on hold. The decision was based on a safety review of reported cerebrovascular events.

August 14, 2014

Regenestem, a division of Global Stem Cells Group Inc., has launched a stem cell treatment center in Cozumel, Mexico. Rafael Moguel, M.D., is the medical director.

August 13, 2014

The science world is mourning the death of a noted Japanese researcher who apparently committed suicide August 5 after being caught up in a scandal over discredited stem cell research.

August 12, 2014

Scientists say that compounds already being tested in clinical trials for other purposes might also be promising candidates for treating amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.

August 6, 2014

Researchers looking to understand how to channel the ability of embryonic stem cells to develop as various cell types into the development of specific types of mature cells have found one potential way—long chains of sugars that dangle from proteins on cells’ surfaces.

August 5, 2014

Researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham), La Jolla, CA, have found that a peptide called caerulein can convert existing cells in the pancreas into the insulin-producing cells destroyed in type 1 diabetes.

Pages